{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_glitazones",
          "name": "Glitazones"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_progestins",
          "name": "Progestins"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_gemfibrozil",
          "type": "Target",
          "label": "Off-target effects of Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_fenofibrate",
          "type": "Target",
          "label": "Off-target effects of Fenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_clofibrate",
          "type": "Target",
          "label": "Off-target effects of Clofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_niacin",
          "type": "Target",
          "label": "Off-target effects of Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_estrogens",
          "type": "Target",
          "label": "Off-target effects of Estrogens",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_thiazolidinediones",
          "type": "Target",
          "label": "Off-target effects of Thiazolidinediones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_hypertriglyceridaemia",
          "type": "Pathway",
          "label": "Risk pathway for Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_hypertriglyceridaemia",
          "type": "Phenotype",
          "label": "Adverse Phenotype from Drug-Induced Hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_gemfibrozil",
          "target": "n_ot_gemfibrozil",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知有影响脂质代谢的旁路"
        },
        {
          "source": "drug_fenofibrate",
          "target": "n_ot_fenofibrate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良脂质水平升高"
        },
        {
          "source": "drug_clofibrate",
          "target": "n_ot_clofibrate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "对脂肪代谢的干预可能加重风险"
        },
        {
          "source": "drug_niacin",
          "target": "n_ot_niacin",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知的副作用与脂质变化相关"
        },
        {
          "source": "drug_estrogens",
          "target": "n_ot_estrogens",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对血脂产生影响"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "n_ot_thiazolidinediones",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与脂质代谢障碍有关"
        },
        {
          "source": "n_ot_gemfibrozil",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能引发脂类代谢异常"
        },
        {
          "source": "n_ot_fenofibrate",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与高甘油三酯风险相关"
        },
        {
          "source": "n_ot_clofibrate",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能加剧高甘油三酯问题"
        },
        {
          "source": "n_ot_niacin",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与脂质问题相互作用"
        },
        {
          "source": "n_ot_estrogens",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能影响甘油三酯水平"
        },
        {
          "source": "n_ot_thiazolidinediones",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与代谢综合征有关"
        },
        {
          "source": "n_rp_hypertriglyceridaemia",
          "target": "n_adv_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致甘油三酯水平显著升高"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Gemfibrozil 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Fenofibrate 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Clofibrate 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Niacin 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Estrogens 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Thiazolidinediones 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Sodium-glucose cotransporter-2 inhibitors 的获益"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "多种药物在高甘油三酯患者中可能导致副作用增加",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "需要考量药物间相互作用使得高甘油三酯风险加剧",
        "confidence": "high"
      }
    ],
    "assumptions_challenged": [
      "药物在严重高甘油三酯患者中的安全性是否得到验证",
      "提到的药物对甘油三酯的影响机制是否一致"
    ],
    "falsification_tests": [
      "是否有研究表明这些药物在高甘油三酯患者中安全有效？",
      "药物是否能有效降低甘油三酯水平而不增加风险？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 解析与高甘油三酯的风险链息息相关的确证证据",
      "评估每种药物在高甘油三酯患者中的效果与安全性"
    ]
  }
}